Muteins of fibroblast growth factor 21

Details for Australian Patent Application No. 2004303783 (hide)

Owner Eli Lilly and Company

Inventors Glaesner, Wolfgang; Rathnachalam, Radhakrishnan; Beals, John Michael; Micanovic, Radmila; Shang, Jing; Li, Shun; Strifler, Beth Ann; Frye, Christopher Carl

Agent Spruson & Ferguson

Pub. Number AU-A-2004303783

PCT Pub. Number WO2005/061712

Priority 60/528,582 10.12.03 US

Filing date 1 December 2004

Wipo publication date 7 July 2005

International Classifications

C07K 14/50 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/061712 Priority application(s): WO2005/061712

11 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004303784-Pyrano-quinolines, pyranoquinolinones, combinations thereof, photochromic compositions and articles

2004303781-Methods of reducing fluid loss in a wellbore servicing fluid